Trials / Completed
CompletedNCT01610479
A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors
A Phase 1 Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Taiho Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase 1 study of TAS-114 in combination with S-1 in patients with advanced solid tumors.
Detailed description
This is a phase 1, open-label, non-randomized, dose-escalating safety, tolerability, and pharmacokinetic study of TAS-114 in combination with S-1 in patients with advanced solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TAS-114 + S-1 |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2012-06-04
- Last updated
- 2017-08-04
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01610479. Inclusion in this directory is not an endorsement.